MATTIE GIROD: Open Payments
NPI 1255818399 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$85 in 4 payments from 4 companies in 2025. Trend: 2023 $20 · 2024 $0 · 2025 $85
Food & beverage: $85
| Company | Payments | Amount |
|---|---|---|
| Merz Pharmaceuticals, LLC | 1 | $30 |
| EMD Serono, Inc. | 1 | $20 |
| Biogen, Inc. | 1 | $19 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $17 |
Products named: INBRIJA, LEQEMBI, REXULTI.
Industry payments across LA — which companies pay providers there.
